HER2-Targeted Therapies in HER2-Low-Expressing Breast Cancer

J Clin Oncol. 2020 Oct 1;38(28):3350-3351. doi: 10.1200/JCO.20.00657. Epub 2020 Jul 13.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Breast Neoplasms* / drug therapy
  • Breast Neoplasms* / genetics
  • Camptothecin / analogs & derivatives
  • Humans
  • Immunoconjugates*
  • Trastuzumab

Substances

  • Immunoconjugates
  • trastuzumab deruxtecan
  • Trastuzumab
  • Camptothecin